08:24 AM EDT, 09/23/2025 (MT Newswires) -- McKesson (MCK) said Tuesday that it now expects fiscal 2026 adjusted earnings of $38.05 to $38.55 per diluted share, up from a prior guidance range of $37.10 to $37.90.

Analysts polled by FactSet expect $37.50.

The company raised its long-term adjusted earnings per share growth target to 13% to 16%, from 12% to 14%.

McKesson also initiated long-term growth targets for its individual segments, expecting 5% to 8% for North American Pharmaceutical, 13% to 16% for Oncology & Multispecialty, and 10% to 13% for Prescription Technology Solutions.

Shares of the company were up 1.4% in recent Tuesday premarket activity.